OXBR vs. RDZN, HIT, ZBAO, AAME, HUIZ, FGF, AIFU, CNFR, TIRX, and UNAM
Should you be buying Oxbridge Re stock or one of its competitors? The main competitors of Oxbridge Re include Roadzen (RDZN), Health In Tech (HIT), Zhibao Technology (ZBAO), Atlantic American (AAME), Huize (HUIZ), Fundamental Global (FGF), AIX (AIFU), Conifer (CNFR), Tian Ruixiang (TIRX), and Unico American (UNAM). These companies are all part of the "insurance" industry.
Oxbridge Re vs.
Oxbridge Re (NASDAQ:OXBR) and Roadzen (NASDAQ:RDZN) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, community ranking, institutional ownership, dividends, profitability and earnings.
Oxbridge Re has higher earnings, but lower revenue than Roadzen. Oxbridge Re is trading at a lower price-to-earnings ratio than Roadzen, indicating that it is currently the more affordable of the two stocks.
Oxbridge Re currently has a consensus target price of $5.00, suggesting a potential upside of 190.70%. Roadzen has a consensus target price of $5.00, suggesting a potential upside of 474.65%. Given Roadzen's higher possible upside, analysts clearly believe Roadzen is more favorable than Oxbridge Re.
Oxbridge Re has a beta of 1.54, suggesting that its stock price is 54% more volatile than the S&P 500. Comparatively, Roadzen has a beta of 0.33, suggesting that its stock price is 67% less volatile than the S&P 500.
Oxbridge Re received 194 more outperform votes than Roadzen when rated by MarketBeat users. However, 100.00% of users gave Roadzen an outperform vote while only 42.00% of users gave Oxbridge Re an outperform vote.
5.6% of Oxbridge Re shares are held by institutional investors. Comparatively, 24.7% of Roadzen shares are held by institutional investors. 19.5% of Oxbridge Re shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
In the previous week, Oxbridge Re had 1 more articles in the media than Roadzen. MarketBeat recorded 1 mentions for Oxbridge Re and 0 mentions for Roadzen. Oxbridge Re's average media sentiment score of 0.00 equaled Roadzen'saverage media sentiment score.
Oxbridge Re has a net margin of 0.00% compared to Roadzen's net margin of -248.79%. Roadzen's return on equity of 0.00% beat Oxbridge Re's return on equity.
Summary
Oxbridge Re beats Roadzen on 9 of the 16 factors compared between the two stocks.
Get Oxbridge Re News Delivered to You Automatically
Sign up to receive the latest news and ratings for OXBR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Oxbridge Re Competitors List
Related Companies and Tools
This page (NASDAQ:OXBR) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy OXBR Stock Free OXBR Stock Alerts